Skip to main content
. 2023 Oct 17;101(16):e1594–e1605. doi: 10.1212/WNL.0000000000207642

Table 2.

Summary of Findings

graphic file with name WNL-2023-000659t2.jpg

Patient or population: Ocular myasthenia gravis
Setting: Hospital
Outcome
No. of participants (studies)		 Relative effect (95% CI) Effect (95% CI) Certainty
SGMG
No. of participants: 3,548 (31 observational)		 — Proportion
0.39 (0.32–0.47)		 ⊕◯◯◯
Very low
RR female sex for SGMG
No. of participants: 1,534 (21 observational studies)		 — RR
1.06 (0.96–1.17)		 ⊕◯◯◯
Very low
RR AChR positivity for SGMG
No. of participants: 1,271 (16 observational studies)		 — RR
1.30 (1.05–1.56)		 ⊕◯◯◯
Very low

Abbreviations: AChR = acetylcholine receptor; RR = risk ratio; SGMG = secondary generalized myasthenia gravis.

GRADE Working Group grades of evidence: High certainty: We are very confident that the true effect lies close to that of the estimate of the effect. Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect. Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect.